Unimark Remedies Limited Health Canada Inspection List
Unimark Remedies Limited Receives FDA Warning Letter
Mumbai-based bulk drugs maker Unimark Remedies is in talks to sell its carbapenen business. Confirming this, a senior company executive told FE talks are currently focused around valuations. “There are several offers and we will decide the final price soon,” the official said. Carbapenens are antibiotics used to treat infections caused by multidrug-resistant bacteria.
Bionpharma, a New Jersey-based pharmaceutical startup founded last year by five former RanbaxyBSE 5.63 % executives and backed by strategic and financial investors, has acquired a portfolio of approximately 25 products from specialty drug maker Banner Life Sciences.
During our March 18-21, 2014 inspection of your pharmaceutical manufacturing facility, Unimark Remedies Ltd., located at 337 Kerala Nalsarovar Road, Kerala Village, Bavla, Ahmedabad District, India, an investigator from the U.S. Food and Drug Administration (FDA) identified significant deviations from current good manufacturing practice (CGMP) for the manufacture of active pharmaceutical ingredients (APIs).